Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 40

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Understanding the Role of Biofilms and Superantigens in Chronic Rhinosinusitis

Maina, Ivy W., Patel, Neil N., Cohen, Noam A. · 2018 · Current Otorhinolaryngology Reports

Abstract

Purpose of ReviewThis review explores recent discoveries in our understanding of how biofilms and superantigens contribute to the pathogenesis of chronic rhinosinusitis (CRS). It also examines clinical implications and novel treatment approaches for biofilm-associated CRS.Recent FindingsWhile the role of biofilms in CRS has been studied for 14 years, research interest has now turned toward elucidating new methods of biofilm detection, microbial diversity, and novel treatment approaches. Recent studies on biofilm superantigens aim to clarify the immunological mechanisms of upper airway inflammation, particularly the type-2 response seen in nasal polyposis.SummaryBiofilms are a topic of research interest for their role in the pathogenesis of chronic rhinosinusitis, particularly when they elute superantigens. New studies on this topic focus on the molecular and cellular mechanisms at play.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s40136-018-0212-6

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 94

  1. Rudmik L. Economics of chronic rhinosinusitis. Curr Allergy Asthma Rep. 2017;17:20. · DOI · Paper page
  2. Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg. 1995;113:104–9. · DOI · Paper page
  3. Dennis SK, Lam K, Luong A. A review of classification schemes for chronic rhinosinusitis with nasal polyposis Endotypes. Laryngoscope Investig Otolaryngol. 2016;1:130–4. · DOI
  4. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15:167–93. · DOI · Paper page
  5. Donlan RM. Biofilms: microbial life on surfaces. Emerg Infect Dis. 2002;8:881–90. · DOI · Paper page
  6. Gilbert P, Das J. Biofilm susceptibility to antimicrobials. Adv Dent Res U. 1997;11:160–7. · DOI · Paper page
  7. Ramakrishnan Y, Shields RC, Elbadawey MR, Wilson JA. Biofilms in chronic rhinosinusitis: what is new and where next? J Laryngol Otol. 2015;129:744–51. · DOI
  8. Boase S, Foreman A, Cleland E, Tan L, Melton-Kreft R, Pant H, et al. The microbiome of chronic rhinosinusitis: culture, molecular diagnostics and biofilm detection. BMC Infect Dis. 2013;13:210. · DOI · Paper page
  9. Chole RA, Faddis BT. Anatomical evidence of microbial biofilms in tonsillar tissues. Arch Otolaryngol Neck Surg. 2003;129:634–6. · DOI · Paper page
  10. Cryer J, Schipor I, Perloff JR, Palmer JN. Evidence of bacterial biofilms in human chronic sinusitis. ORL. 2004;66:155–8. · DOI · Paper page
  11. Tatar EÇ, Tatar İ, Öcal B, Korkmaz H, Saylam G, Özdek A, et al. Prevalence of biofilms and their response to medical treatment in chronic rhinosinusitis without polyps. Otolaryngol Neck Surg. 2012;146:669–75. · DOI
  12. Foreman A, Psaltis AJ, Tan LW, Wormald P-J. Characterization of bacterial and fungal biofilms in chronic rhinosinusitis. Allergy Rhinol. 2010;1:10. · DOI · Paper page
  13. Singhal D, Psaltis AJ, Foreman A, Wormald P-J. The impact of biofilms on outcomes after endoscopic sinus surgery. Am J Rhinol Allergy. 2010;24:169–74. · DOI · Paper page
  14. Lee RJ, Cohen NA. Bitter and sweet taste receptors in the respiratory epithelium in health and disease. J Mol Med (Berl). 2014;92:1235–44. · DOI
  15. Zhang Y, Hoon MA, Chandrashekar J, Mueller KL, Cook B, Wu D, et al. Coding of sweet, bitter, and umami tastes. Cell. 2003;112:293–301. · DOI · Paper page
  16. Lee RJ, Xiong G, Kofonow JM, Chen B, Lysenko A, Jiang P, et al. T2R38 taste receptor polymorphisms underlie susceptibility to upper respiratory infection. J Clin Invest. 2012;122:4145–59. · DOI · Paper page
  17. Lee RJ, Chen B, Redding KM, Margolskee RF, Cohen NA. Mouse nasal epithelial innate immune responses to Pseudomonas aeruginosa quorum-sensing molecules require taste signaling components. Innate Immun. 2014;20:606–17. · DOI
  18. Meyerhof W, Batram C, Kuhn C, Brockhoff A, Chudoba E, Bufe B, et al. The molecular receptive ranges of human TAS2R bitter taste receptors. Chem Senses. 2010;35:157–70. · DOI · Paper page
  19. Bufe B, Breslin PAS, Kuhn C, Reed DR, Tharp CD, Slack JP, et al. The molecular basis of individual differences in phenylthiocarbamide and Propylthiouracil bitterness perception. Curr Biol. 2005;15:322–7. · DOI · Paper page
  20. Workman AD, Brooks SG, Kohanski MA, Blasetti MT, Cowart BJ, Mansfield C, et al. Bitter and sweet taste tests are reflective of disease status in chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2017;6:1078–80. https://doi.org/10.1016/j.jaip.2017.09.014 . · DOI
  21. Jia M, Chen Z, Du X, Guo Y, Sun T, Zhao X. A simple animal model of Staphylococcus aureus biofilm in sinusitis. Am J Rhinol Allergy. 2014;28:115–9. · doi:10.2500/ajra.2014.28.4030
  22. Dlugaszewska J, Leszczynska M, Lenkowski M, Tatarska A, Pastusiak T, Szyfter W. The pathophysiological role of bacterial biofilms in chronic sinusitis. Eur Arch Otorhinolaryngol. 2016;273:1989–94. · DOI
  23. Galli J, Calò L, Ardito F, Imperiali M, Bassotti E, Cesare Passali G, et al. Damage to ciliated epithelium in chronic rhinosinusitis: what is the role of bacterial biofilms? Ann Otol Rhinol Laryngol. 2008;117:902–8. · DOI
  24. Mao Y-J, Chen H-H, Wang B, Liu X, Xiong G-Y. Increased expression of MUC5AC and MUC5B promoting bacterial biofilm formation in chronic rhinosinusitis patients. Auris Nasus Larynx. 2015;42:294–8. · DOI
  25. Tan NC-W, Foreman A, Jardeleza C, Douglas R, Vreugde S, Wormald P-J. Intracellular Staphylococcus aureus : the Trojan horse of recalcitrant chronic rhinosinusitis? Int Forum Allergy Rhinol. 2013;3:261–6. · DOI
  26. Cantero D, Cooksley C, Bassiouni A, Wormald P-J, Vreugde S. Staphylococcus aureus biofilm activates the nucleotide-binding oligomerization domain containing 2 (Nod2) pathway and proinflammatory factors on a human sinonasal explant model. Int Forum Allergy Rhinol. 2013;3:877–84. · doi:10.1002/alr.21213
  27. Jardeleza C, Miljkovic D, Baker L, Boase S, Tan NC, Koblar SA, et al. Inflammasome gene expression alterations in Staphylococcus aureus biofilm-associated chronic rhinosinusitis. Rhinology. 2013;51:315–22. · doi:10.4193/rhin13.045
  28. Dong D, Yulin Z, Xiao W, Hongyan Z, Jia L, Yan X, et al. Correlation between bacterial biofilms and osteitis in patients with chronic rhinosinusitis. Laryngoscope. 2014;124:1071–7. · DOI
  29. Karosi T, Csomor P, Hegyi Z, Sziklai I. The presence of CD209 expressing dendritic cells correlates with biofilm positivity in chronic rhinosinusitis with nasal polyposis. Eur Arch Oto-Rhino-Laryngology. 2013;270:2455–63. · DOI
  30. Arjomandi H, Gilde J, Zhu S, Delaney S, Hochstim C, Mazhar K, et al. Relationship of eosinophils and plasma cells to biofilm in chronic rhinosinusitis. Am J Rhinol Allergy. 2013;27:85–90. · DOI
  31. Wang X, Dong D, Cheng J, Fan X, Zhao Y. Relationship between biofilms and clinical features in patients with sinus fungal ball. Eur Arch Oto-Rhino-Laryngology. 2015;272:2363–9. · DOI
  32. Głowacki R, Tomaszewski KA, Stręk P, Tomaszewska IM, Zgórska-Świerzy K, Markiewicz B, et al. The influence of bacterial biofilm on the clinical outcome of chronic rhinosinusitis: a prospective, double-blind, scanning electron microscopy study. Eur Arch Oto-Rhino-Laryngology. 2014;271:1015–21. · DOI
  33. Zhang Z, Adappa ND, Chiu AG, Doghramji LJ, Cohen NA, Palmer JN. Biofilm-forming bacteria and quality of life improvement after sinus surgery. Int Forum Allergy Rhinol. 2015;5:643–9. · DOI · Paper page
  34. Zhang Z, Linkin DR, Finkelman BS, O’Malley BW, Thaler ER, Doghramji L, et al. Asthma and biofilm-forming bacteria are independently associated with revision sinus surgeries for chronic rhinosinusitis. J Allergy Clin Immunol. 2011;128:221–223.e1. · DOI
  35. Singhal D, Foreman A, Jervis-Bardy J, Bardy J-J, Wormald P-J. Staphylococcus aureus biofilms: Nemesis of endoscopic sinus surgery. Laryngoscope. 2011;121:1578–83. · DOI
  36. Watson ARO, Janik DK, Lee WT. Superantigen-induced CD4 memory T cell anergy. I. Staphylococcal enterotoxin B induces Fyn-mediated negative signaling. Cell Immunol. 2012;276:16–25. · DOI
  37. William T Lee DKJ (2015) Staphylococcal enterotoxin B (SEB) induces memory CD4 T cell Anergy in vivo and impairs recall immunity to unrelated antigens. J Clin Cell Immunol 06. https://doi.org/10.4172/2155-9899.1000346 . · DOI
  38. Seiberling KA, Grammer LC, Kern RC. Chronic rhinosinusitis and superantigens. Rhinol Facial Plast Surg. 2009;38:231–9. · DOI
  39. Spaulding AR, Salgado-Pabón W, Kohler PL, Horswill AR, Leung DYM, Schlievert PM. Staphylococcal and streptococcal superantigen exotoxins. Clin Microbiol Rev. 2013;26:422–47. · DOI · Paper page
  40. Krakauer T, Stiles BG. The staphylococcal enterotoxin (SE) family: SEB and siblings. Virulence. 2013;4:759–73. https://doi.org/10.4161/viru.23905 . · DOI
  41. Proft T, Fraser JD. Bacterial superantigens. Clin Exp Immunol. 2003;133:299–306. · DOI · Paper page
  42. Fraser JD, Proft T. The bacterial superantigen and superantigen-like proteins. Immunol Rev. 2008;225:226–43. · DOI · Paper page
  43. Bohach GA, Fast DJ, Nelson RD, Schlievert PM. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol. 1990;17:251–72. · DOI · Paper page
  44. Kappler J, Kotzin B, Herron L, Gelfand EW, Bigler RD, Boylston a CS, et al. V beta-specific stimulation of human T cells by staphylococcal toxins. Science. 1989;244:811–3. · DOI · Paper page
  45. Llewelyn M, Sriskandan S, Terrazzini N, Cohen J, Altmann DM. The TCR Vβ signature of bacterial superantigens spreads with stimulus strength. Int Immunol. 2006;18:1433–41. · DOI
  46. Ferry T, Thomas D, Perpoint T, Lina G, Monneret G, Mohammedi I, et al. Analysis of superantigenic toxin Vβ T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock. Clin Microbiol Infect. 2008;14:546–54. · doi:10.1111/j.1469-0691.2008.01975.x
  47. Conley DB, Tripathi A, Seiberling KA, Schleimer RP, Suh LA, Harris K, et al. Superantigens and chronic rhinosinusitis: skewing of T-cell receptor V beta-distributions in polyp-derived CD4+ and CD8+ T cells. Am J Rhinol. 2006;20:534–9. · DOI
  48. Thibodeau J, Dohlsten M, Cloutier I, Lavoie PM, Bjork P, Michel F, et al. Molecular characterization and role in T cell activation of staphylococcal enterotoxin a binding to the HLA-DR alpha-chain. JImmunol. 1997;158:3698–704. · doi:10.4049/jimmunol.158.8.3698
  49. Sachse F, Becker K, Von Eiff C, Metze D, Rudack C. Staphylococcus aureus invades the epithelium in nasal polyposis and induces IL-6 in nasal epithelial cells in vitro. Allergy Eur J Allergy Clin Immunol. 2010;65:1430–7. · DOI
  50. Patou J, Gevaert P, Van Zele T, Holtappels G, van Cauwenberge P, Bachert C. Staphylococcus aureus enterotoxin B, protein a, and lipoteichoic acid stimulations in nasal polyps. J Allergy Clin Immunol. 2008;121:110–5. · DOI · Paper page
  51. Foreman A, Holtappels G, Psaltis AJ, Jervis-Bardy J, Field J, Wormald P-J, et al. Adaptive immune responses in Staphylococcus aureus biofilm-associated chronic rhinosinusitis. Allergy. 2011;66:1449–56. · DOI
  52. Gevaert P, Holtappels G, Johansson SGO, Cuvelier C, Van Cauwenberge P, Bachert C. Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue. Allergy Eur J Allergy Clin Immunol. 2005;60:71–9. · DOI · Paper page
  53. El Fiky LM, Khamis N, El Din Mostafa D, Adly AM. Staphylococcal infection and toxin production in chronic rhinosinusitis. AmJRhinolAllergy. 2009;23:264–7.
  54. Wang M, Zhang D, Zhang H, Wang Z, Chen X, Jian J. a primary study about the correlation between superantigens produced by Staphylococcus aureus and chronic rhinosinusitis with nasal polyps. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2006;20:914–6.
  55. Bachert C, Gevaert P, Zhang N, van Zele T, Perez-Novo C. Role of staphylococcal Superantigens in airway disease. Superantigens and Superallergens. 2007;93:214–36. · DOI
  56. Guven M, Karabay O, Akidil O, Yilmaz MS, Yildirim M. Detection of staphylococcal exotoxins in antrochoanal polyps and chronic rhinosinusitis with nasal polyps. Otolaryngol-Head Neck Surg (United States). 2013;148:302–7. · DOI
  57. Wang M, Shi P, Chen B, Zhang H, Jian J, Chen X, et al. The role of Superantigens in chronic rhinosinusitis with nasal polyps. ORL. 2008;70:97–103. · DOI
  58. Seon TK, Seung WC, Joo HJ, Jong SH, Il GK. Association of T cells and eosinophils with Staphylococcus aureus exotoxin a and toxic shock syndrome toxin 1 in nasal polyps. Am J Rhinol Allergy. 2011;25:19–24. · DOI
  59. Ramakrishnan VR, Feazel LM, Abrass LJ, Frank DN. Prevalence and abundance of Staphylococcus aureus in the middle meatus of patients with chronic rhinosinusitis, nasal polyps, and asthma. Int Forum Allergy Rhinol. 2013;3:267–71. · DOI
  60. Zhang N, Gevaert P, van Zele T, Perez-Novo C, Patou J, Holtappels G, et al. An update on the impact of Staphylococcus aureus enterotoxins in chronic sinusitis with nasal polyposis. Rhinology. 2005;43:162–8.
  61. Ou J, Wang J, Xu Y, zhang TZ, Kong YG, Chen SM, et al. Staphylococcus aureus superantigens are associated with chronic rhinosinusitis with nasal polyps: a meta-analysis. Eur Arch Oto-Rhino-Laryngology. 2014;271:2729–36. · DOI
  62. Li Z, Levast B, Madrenas J. Staphylococcus aureus downregulates IP-10 production and prevents Th1 cell recruitment. J Immunol. 2017;198:1865–74. · DOI
  63. Conley DB, Tripathi A, Ditto AM, Reid K, Grammer LC, Kern RC. Chronic sinusitis with nasal polyps: staphylococcal exotoxin immunoglobulin E and cellular inflammation. Am J Rhinol. 2004;18:273–8. · DOI
  64. Tripathi A, Conley DB, Grammer LC, Ditto AM, Lowery MM, Seiberling KA, et al. Immunoglobulin E to staphylococcal and streptococcal toxins in patients with chronic sinusitis/nasal polyposis. Laryngoscope. 2004;114:1822–6. · DOI
  65. Cui X, Miao J, Lu H, Qi Q, Chen X, Xu J, et al. Serum levels of specific IgE to Staphylococcus aureus enterotoxins in patients with chronic rhinosinusitis. Exp Ther Med. 2015;9:1523–7. · DOI
  66. Van Zele T, Gevaert P, Watelet J-B, Claeys G, Holtappels G, Claeys C, et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol. 2004;114:981–3. · DOI · Paper page
  67. Wang JH, Kwon HJ, Jang YJ. Staphylococcus aureus increases cytokine and matrix metalloproteinase expression in nasal mucosae of patients with chronic rhinosinusitis and nasal polyps. Am J Rhinol Allergy. 2010;24:422–7. · doi:10.2500/ajra.2010.24.3509
  68. Korkmaz H, Öcal B, Tatar EÇ, Tatar I, Özdek A, Saylam G, et al. Biofilms in chronic rhinosinusitis with polyps: is eradication possible? Eur Arch Oto-Rhino-Laryngol. 2014;271:2695–702. · DOI
  69. Ezzat WF, Fawaz SA, Rabie H, Hamdy TA, Shokry YA. Effect of topical ofloxacin on bacterial biofilms in refractory post-sinus surgery rhino-sinusitis. Eur Arch Oto-Rhino-Laryngol. 2015;272:2355–61. · doi:10.1007/s00405-014-3301-2
  70. Chiu AG, Antunes MB, Palmer JN, Cohen NA. Evaluation of the in vivo efficacy of topical tobramycin against Pseudomonas sinonasal biofilms. J Antimicrob Chemother. 2007;59:1130–4. · DOI
  71. Lee JT, Chiu AG. Topical anti-infective sinonasal irrigations: update and literature review. Am J Rhinol Allergy. 2014;28:29–38. · DOI
  72. El Haj C, Murillo O, Ribera A, Garcia-Somoza D, Tubau F, Cabellos C, et al. The anti-biofilm effect of macrolides in a rat model of S. Aureus foreign-body infection: might it be of clinical relevance? Med Microbiol Immunol. 2017;206:31–9. · doi:10.1007/s00430-016-0479-5
  73. Head K, Chong LY, Piromchai P, Hopkins C, Philpott C, Schilder AG, et al. Systemic and topical antibiotics for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016;4:CD011994.
  74. Smith SS, Evans CT, Tan BK, Chandra RK, Smith SB, Kern RC. National burden of antibiotic use for adult rhinosinusitis. J Allergy Clin Immunol. 2013;132:1230–2. · DOI
  75. Cirkovic I, Pavlovic B, Bozic DD, Jotic A, Bakic L, Milovanovic J. Antibiofilm effects of topical corticosteroids and intranasal saline in patients with chronic rhinosinusitis with nasal polyps depend on bacterial species and their biofilm-forming capacity. Eur Arch Oto-Rhino-Laryngol. 2017;274:1897–903. · DOI
  76. Alandejani T, Marsan J, Ferris W, Slinger R, Chan F. Effectiveness of honey on Staphylococcus aureus and Pseudomonas aeruginosa biofilms. Otolaryngol Neck Surg. 2009;141:114–8. · DOI · Paper page
  77. Paramasivan S, Drilling AJ, Jardeleza C, Jervis-Bardy J, Vreugde S, Wormald PJ. Methylglyoxal-augmented manuka honey as a topical anti-Staphylococcus aureus biofilm agent: safety and efficacy in an in vivo model. Int Forum Allergy Rhinol. 2014;4:187–95. · DOI
  78. Biel MA, Pedigo L, Gibbs A, Loebel N. Photodynamic therapy of antibiotic-resistant biofilms in a maxillary sinus model. Int Forum Allergy Rhinol. 2013;3:468–73. · doi:10.1002/alr.21134
  79. Bryce E, Wong T, Forrester L, Masri B, Jeske D, Barr K, et al. Nasal photodisinfection and chlorhexidine wipes decrease surgical site infections: a historical control study and propensity analysis. J Hosp Infect. 2014;88:89–95. · doi:10.1016/j.jhin.2014.06.017
  80. Monzavi A, Chinipardaz Z, Mousavi M, Fekrazad R, Moslemi N, Azaripour A, et al. Antimicrobial photodynamic therapy using diode laser activated indocyanine green as an adjunct in the treatment of chronic periodontitis: a randomized clinical trial. Photodiagn Photodyn Ther. 2016;14:93–7. · DOI
  81. Vassena C, Fenu S, Giuliani F, Fantetti L, Roncucci G, Simonutti G, et al. Photodynamic antibacterial and antibiofilm activity of RLP068/cl against Staphylococcus aureus and Pseudomonas aeruginosa forming biofilms on prosthetic material. Int J Antimicrob Agents. 2014;44:47–55. · DOI
  82. Biel MA, Jones JW, Pedigo L, Gibbs A, Loebel N. The effect of antimicrobial photodynamic therapy on human ciliated respiratory mucosa. Laryngoscope. 2012;122:2628–31. · DOI
  83. Ansari NN, Naghdi S, Fathali M, Bartley J, Rastak MS. A randomized clinical trial comparing pulsed ultrasound and erythromycin phonophoresis in the treatment of patients with chronic rhinosinusitis. Physiother Theory Pract. 2015;31:166–72. · doi:10.3109/09593985.2014.991465
  84. Foreman A, Jervis-Bardy J, Boase SJ, Tan L, Wormald P-J. Noninvasive Staphylococcus aureus biofilm determination in chronic rhinosinusitis by detecting the exopolysaccharide matrix component poly- N -acetylglucosamine. Int Forum Allergy Rhinol. 2013;3:83–8. · DOI
  85. Bernstein JM, Kansal R. Superantigen hypothesis for the early development of chronic hyperplastic sinusitis with massive nasal polyposis. Curr Opin Otolaryngol Head Neck Surg. 2005;13:39–44. · DOI
  86. Tripathi A, Kern R, Conley DB, Seiberling K, Klemens JC, Harris KE, et al. Staphylococcal exotoxins and nasal polyposis: analysis of systemic and local responses. Am J Rhinol. 2005;19:327–33. · DOI
  87. Schubert MS. A superantigen hypothesis for the pathogenesis of chronic hypertrophic rhinosinusitis, allergic fungal sinusitis, and related disorders. Ann Allergy Asthma Immunol. 2001;87:181–8. · DOI
  88. Gabra N, Alromaih S, Endam LM, Brito RM, Larivière F, Al-Mot S, et al. Clinical features of cytotoxic CD8+ T-lymphocyte deficiency in chronic rhinosinusitis patients: a demographic and functional study. Int Forum Allergy Rhinol. 2014;4:495–501. · DOI
  89. Ou J, Bassiouni A, Drilling A, Psaltis AJ, Vreugde S, Wormald PJ. The persistence of intracellular Staphylococcus aureus in the sinuses: a longitudinal study. Rhinology. 2017;55:305–11. · doi:10.4193/rhin16.218
  90. Forster U, Strathmann S, Schafer D, Szczepek AJ, Olze H. Eicosanoid imbalance correlates in vitro with the pattern of clinical symptoms of Samter ́s triad. Rhinology. 2013;51:61–9. · doi:10.4193/rhin12.117
  91. Roca-Ferrer J, Garcia-Garcia FJ, Pereda J, Perez-Gonzalez M, Pujols L, Alobid I, et al. Reduced expression of COXs and production of prostaglandin E2 in patients with nasal polyps with or without aspirin-intolerant asthma. J Allergy Clin Immunol. 2011;128:66–72. · DOI
  92. Pérez-Novo CA, Waeytens A, Claeys C, Van Cauwenberge P, Bachert C. Staphylococcus aureus enterotoxin B regulates prostaglandin E2 synthesis, growth, and migration in nasal tissue fibroblasts. J Infect Dis. 2008;197:1036–43. · DOI
  93. Okano M, Fujiwara T, Haruna T, Kariya S, Makihara S, Higaki T, et al. Prostaglandin E2 suppresses staphylococcal enterotoxin-induced eosinophilia-associated cellular responses dominantly through an E-prostanoid 2-mediated pathway in nasal polyps. J Allergy Clin Immunol. 2009;123:868–874.e13. https://doi.org/10.1016/j.jaci.2009.01.047 . · DOI
  94. Mruwat R, Kivity S, Landsberg R, Yedgar S, Langier S. Phospholipase A2-dependent release of inflammatory cytokines by superantigen-stimulated nasal polyps of patients with chronic rhinosinusitis. Am J Rhinol Allergy. 2015;29:e122–8. · doi:10.2500/ajra.2015.29.4224

Cited by

See all 40

Metadata

Authors
Maina, I. W., Patel, N. N., & Cohen, N. A.
Venue
Current Otorhinolaryngology Reports
Published
2018-07-26
Volume
6
Issue
3
Pages
253-262
ISSN
2167-583X
Cited by
40
References
2
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Understanding the Role of Biofilms and Superantigens in Chronic Rhinosinusitis. https://app.cochat.ai/papers/10.1007/s40136-018-0212-6
The paper
Maina, I. W., Patel, N. N., & Cohen, N. A. (2018). Understanding the Role of Biofilms and Superantigens in Chronic Rhinosinusitis. Current Otorhinolaryngology Reports. https://doi.org/10.1007/s40136-018-0212-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.